Status:
RECRUITING
Epidemiological Study of a Prospective Cohort of Patients Aged 60 and Over Managed for Acute Myeloid Leukemia (AML) and Receiving Intensive Induction Therapy
Lead Sponsor:
French Innovative Leukemia Organisation
Conditions:
AML, Adult
Eligibility:
All Genders
60+ years
Brief Summary
This observational epidemiological study targets patients aged 60 and over with de novo or secondary acute myeloblastic leukemia suitable for intensive receive intensive induction therapy as defined b...
Eligibility Criteria
Inclusion
- Patients aged 60 and over
- Patients with previously untreated de novo or secondary AML
- Patients suitable for standard intensive treatment
- Patients who have read the information document and agreed to the collection of data concerning them (signature of informed consent).
Exclusion
- Patients with AML 3
- Patients with severe, uncontrolled infection at the time of inclusion
- Patients with psychiatric or social disorders that will prevent compliance with the protocol
- Patients without health insurance (affiliation to a social security scheme)
Key Trial Info
Start Date :
January 6 2015
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 6 2031
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT06891144
Start Date
January 6 2015
End Date
January 6 2031
Last Update
March 24 2025
Active Locations (27)
Enter a location and click search to find clinical trials sorted by distance.
1
Angers CHU
Angers, France
2
Annecy CH
Annecy, France
3
Avignon CH
Avignon, France
4
Bayonne CH
Bayonne, France